{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-005670","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2022-02-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.087351+00:00","generated_at":"2026-06-27T07:18:38.936034+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nu Skin Q4 rev $673M (-10%), adj EPS $1.11; FY22 guidance rev $2.66-2.77B, EPS $4.05-4.45","bullets":["Q4 2021 revenue $673.4M, down 10% YoY; customers down 12% to 1.37M, sales leaders down 13% to 61,515.","Adjusted EPS (excl. restructuring/impairment) $1.11 vs $1.40; GAAP EPS $(0.18) due to $58.5M Grow Tech exit charge.","Full-year 2021 revenue $2.70B (+4% YoY); adjusted EPS $4.14 vs $3.63.","Q1 2022 guidance: rev $560-590M, EPS $0.65-0.75; FY22 rev $2.66-2.77B, EPS $4.05-4.45.","Introduced Nu Vision 2025 strategy focused on personalized beauty/wellness and affiliate social commerce."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-005670","json":"https://secwatch.observer/filing/0001140361-22-005670.json","markdown":"https://secwatch.observer/filing/0001140361-22-005670.md","text":"https://secwatch.observer/filing/0001140361-22-005670.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036122005670/0001140361-22-005670-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036122005670/brhc10034081_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T07:18:38.936034+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}